Details for Patent: 8,883,794
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 8,883,794 protect, and when does it expire?
Patent 8,883,794 protects LATUDA and is included in one NDA.
Protection for LATUDA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty-four patent family members in twenty-one countries.
Summary for Patent: 8,883,794
Title: | Pharmaceutical composition |
Abstract: | A preparation for oral administration comprising: a pregelatinized starch comprising N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethyle- ne-butyl]-(1'R,2'S,3'R,4'S)-2,3-bicyclo[2,2,1]-heptanedicarboxylmide hydrochloride (lurasidone) represented by the formula (1) as an active ingredient; a water-soluble excipient; and a water-soluble polymeric binder, the preparation exhibiting an invariant level of elution behavior even when the content of its active ingredient is varied. |
Inventor(s): | Fujihara; Kazuyuki (Suzuka, JP) |
Assignee: | Sumitomo Dainippon Pharma Co., Ltd. (Osaka, JP) |
Application Number: | 14/183,283 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,883,794 |
Patent Claim Types: see list of patent claims | Composition; Compound; Dosage form; |
Drugs Protected by US Patent 8,883,794
International Family Members for US Patent 8,883,794
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2006250340 | See Plans and Pricing | |||
Brazil | 122020005056 | See Plans and Pricing | |||
Brazil | PI0611409 | See Plans and Pricing | |||
Canada | 2606510 | See Plans and Pricing | |||
China | 101184489 | See Plans and Pricing | |||
China | 102048734 | See Plans and Pricing | |||
Cyprus | 1114118 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |